Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRIM24 | O15164 | 2/20 | 0.38 |
| ▸ | TRIM33 | Q9UPN9 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | CA12 | O43570 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CA3 | P07451 | 1/20 | 0.33 |
| ▸ | CA4 | P22748 | 1/20 | 0.33 |
| ▸ | CA6 | P23280 | 1/20 | 0.33 |
| ▸ | CA5A | P35218 | 1/20 | 0.33 |
| ▸ | CA7 | P43166 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.33 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.33 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.33 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9494995 | 0.81 | — | — | |
| SCHEMBL70684 | 0.81 | — | — | |
| SCHEMBL9497220 | 0.81 | — | — | |
| Carbamic Acid SCHEMBL30075069 | 0.75 | SLC1A2 (0.34) | CA1CA2 | |
| Cyclohexanone SCHEMBL977979 | 0.72 | ALDH1A1 (0.58) | TRIM24TRIM33ALDH1A1LMNA | |
| Cyclohexanone SCHEMBL11783871 | 0.72 | ALDH1A1 (0.58) | TRIM24TRIM33ALDH1A1LMNA | |
| Cyclopentanone SCHEMBL3625536 | 0.72 | ALDH1A1 (0.58) | TRIM24TRIM33ALDH1A1LMNA | |
| Cyclohexanone SCHEMBL5796695 | 0.71 | ALDH1A1 (0.55) | TRIM24TRIM33ALDH1A1 | |
| Propionitrile SCHEMBL11561043 | 0.71 | ALDH1A1 (0.55) | TRIM24TRIM33ALDH1A1 | |
| Cyclohexanone SCHEMBL27512130 | 0.70 | TRIM24 (0.61) | TRIM24TRIM33ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-54047882-A | — | — | None | — | — | JP | disclosed |
| US-6881843-B2 | Process for production of gabapentin intermediate | TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) | 2005-04-19 | — | — | US | disclosed |
| US-20030195358-A1 | Process for production of gabapentin intermediate | MONTANARI STEFANIA MARIA PAOLA (IT) | 2003-10-16 | — | — | US | disclosed |
| US-6613904-B2 | Reacting cyclohexanone with ethylcyanoacetate in the presence of ammonium hydroxide to form alpha, alpha'-dicyano-beta, beta-pentamethyleneglutarimide | TEVA PHARMACEUTICAL INDUSTRIES, LTD (IL) | 2003-09-02 | — | — | US | disclosed |
| US-20020107395-A1 | Process for production of gabapentin intermediate | TEVA PHARMACEUTICALS INDUSTRIES LTD. (IL) | 2002-08-08 | — | — | US | disclosed |
| JP-S5447882-A | ELECTROCHROMIC DISPLAY ELEMENT | SHARP CORP | 1979-04-14 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020107395-A1 | Process for production of gabapentin intermediate | OGDH, BCKDK, GABRE | TRIM24 1920/4885TRIM33 2924/4885ALDH1A1 794/4885 |
| US-20030195358-A1 | Process for production of gabapentin intermediate | OGDH, BCKDK, GABRE | TRIM24 1920/4885TRIM33 2924/4885ALDH1A1 794/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.